[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Antihypertensive Drug Market Report to 2021

November 2016 | 104 pages | ID: E9ACAD055E1EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Antihypertensive Drug

Revenue, means the sales value of Antihypertensive Drug

This report studies sales (consumption) of Antihypertensive Drug in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Novartis
  • Pfizer, Inc.
  • Roche
  • Sanofi
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • AstraZeneca plc.
  • Eli Lilly and Company
  • Abbvie
  • AMGen
  • Teva Pharmaceutical Industries Ltd.
  • Bayer AG
  • Bristol-Myers Squibb
  • Astellas Pharma
  • Daiichi Sankyo
  • Abbott Laboratories
  • Yangtze River Pharmaceutical Group
  • Boehringer-Ingelheim
Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Antihypertensive Drug in these regions, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Central Antihypertensive Drug
  • An Antihypertensive Agent Acting on the Sympathetic Nervous System
  • Ganglion Block Drugs
  • Vasodilators
  • Adrenergic Alpha 1 Receptor Antagonist
  • Drugs that Affect the Renin-angiotensin-aldosterone System
  • Calcium Channel Blockers
Split by applications, this report focuses on sales, market share and growth rate of Antihypertensive Drug in each application, can be divided into
  • First Level Hospital
  • Two Level Hospital
  • Three Level Hospital
  • Others
1 ANTIHYPERTENSIVE DRUG OVERVIEW

1.1 Product Overview and Scope of Antihypertensive Drug
1.2 Classification of Antihypertensive Drug
  1.2.1 Central Antihypertensive Drug
  1.2.2 An Antihypertensive Agent Acting on the Sympathetic Nervous System
  1.2.3 Ganglion Block Drugs
  1.2.4 Vasodilators
  1.2.5 Adrenergic Alpha 1 Receptor Antagonist
  1.2.6 Drugs that Affect the Renin-angiotensin-aldosterone System
  1.2.7 Calcium Channel Blockers
1.3 Applications of Antihypertensive Drug
  1.3.1 First Level Hospital
  1.3.2 Two Level Hospital
  1.3.3 Three Level Hospital
  1.3.4 Others
1.4 Antihypertensive Drug Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Antihypertensive Drug (2011-2021)
  1.5.1 Europe Antihypertensive Drug Sales, Revenue and Price (2011-2021)
  1.5.2 Europe Antihypertensive Drug Sales and Growth Rate (2011-2021)
  1.5.3 Europe Antihypertensive Drug Revenue and Growth Rate (2011-2021)

2 EUROPE ANTIHYPERTENSIVE DRUG BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Antihypertensive Drug Market Competition by Manufacturers
  2.1.1 Europe Antihypertensive Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Antihypertensive Drug Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Antihypertensive Drug (Volume and Value) by Type
  2.2.1 Europe Antihypertensive Drug Sales and Market Share by Type (2011-2021)
  2.2.2 Europe Antihypertensive Drug Revenue and Market Share by Type (2011-2021)
2.3 Europe Antihypertensive Drug (Volume and Value) by Regions
  2.3.1 Europe Antihypertensive Drug Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe Antihypertensive Drug Revenue and Market Share by Regions (2011-2021)
2.4 Europe Antihypertensive Drug (Volume) by Application

3 GERMANY ANTIHYPERTENSIVE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Antihypertensive Drug Sales and Value (2011-2021)
  3.1.1 Germany Antihypertensive Drug Sales and Growth Rate (2011-2021)
  3.1.2 Germany Antihypertensive Drug Revenue and Growth Rate (2011-2021)
  3.1.3 Germany Antihypertensive Drug Sales Price Trend (2011-2021)
3.2 Germany Antihypertensive Drug Sales and Market Share by Manufacturers
3.3 Germany Antihypertensive Drug Sales and Market Share by Type
3.4 Germany Antihypertensive Drug Sales and Market Share by Applications

4 UK ANTIHYPERTENSIVE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 UK Antihypertensive Drug Sales and Value (2011-2021)
  4.1.1 UK Antihypertensive Drug Sales and Growth Rate (2011-2021)
  4.1.2 UK Antihypertensive Drug Revenue and Growth Rate (2011-2021)
  4.1.3 UK Antihypertensive Drug Sales Price Trend (2011-2021)
4.2 UK Antihypertensive Drug Sales and Market Share by Manufacturers
4.3 UK Antihypertensive Drug Sales and Market Share by Type
4.4 UK Antihypertensive Drug Sales and Market Share by Applications

5 FRANCE ANTIHYPERTENSIVE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 France Antihypertensive Drug Sales and Value (2011-2021)
  5.1.1 France Antihypertensive Drug Sales and Growth Rate (2011-2021)
  5.1.2 France Antihypertensive Drug Revenue and Growth Rate (2011-2021)
  5.1.3 France Antihypertensive Drug Sales Price Trend (2011-2021)
5.2 France Antihypertensive Drug Sales and Market Share by Manufacturers
5.3 France Antihypertensive Drug Sales and Market Share by Type
5.4 France Antihypertensive Drug Sales and Market Share by Applications

6 ITALY ANTIHYPERTENSIVE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Italy Antihypertensive Drug Sales and Value (2011-2021)
  6.1.1 Italy Antihypertensive Drug Sales and Growth Rate (2011-2021)
  6.1.2 Italy Antihypertensive Drug Revenue and Growth Rate (2011-2021)
  6.1.3 Italy Antihypertensive Drug Sales Price Trend (2011-2021)
6.2 Italy Antihypertensive Drug Sales and Market Share by Manufacturers
6.3 Italy Antihypertensive Drug Sales and Market Share by Type
6.4 Italy Antihypertensive Drug Sales and Market Share by Applications

7 RUSSIA ANTIHYPERTENSIVE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Russia Antihypertensive Drug Sales and Value (2011-2021)
  7.1.1 Russia Antihypertensive Drug Sales and Growth Rate (2011-2021)
  7.1.2 Russia Antihypertensive Drug Revenue and Growth Rate (2011-2021)
  7.1.3 Russia Antihypertensive Drug Sales Price Trend (2011-2021)
7.2 Russia Antihypertensive Drug Sales and Market Share by Manufacturers
7.3 Russia Antihypertensive Drug Sales and Market Share by Type
7.4 Russia Antihypertensive Drug Sales and Market Share by Applications

8 SPAIN ANTIHYPERTENSIVE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Antihypertensive Drug Sales and Value (2011-2021)
  8.1.1 Spain Antihypertensive Drug Sales and Growth Rate (2011-2021)
  8.1.2 Spain Antihypertensive Drug Revenue and Growth Rate (2011-2021)
  8.1.3 Spain Antihypertensive Drug Sales Price Trend (2011-2021)
8.2 Spain Antihypertensive Drug Sales and Market Share by Manufacturers
8.3 Spain Antihypertensive Drug Sales and Market Share by Type
8.4 Spain Antihypertensive Drug Sales and Market Share by Applications

9 EUROPE ANTIHYPERTENSIVE DRUG MANUFACTURERS ANALYSIS

9.1 Novartis
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 Antihypertensive Drug Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Antihypertensive Drug Sales, Revenue, Price of Novartis (2015 and 2016)
9.2 Pfizer, Inc.
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 Antihypertensive Drug Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Antihypertensive Drug Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
9.3 Roche
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 Antihypertensive Drug Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Antihypertensive Drug Sales, Revenue, Price of Roche (2015 and 2016)
9.4 Sanofi
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 Antihypertensive Drug Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Antihypertensive Drug Sales, Revenue, Price of Sanofi (2015 and 2016)
9.5 Merck & Co., Inc.
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 Antihypertensive Drug Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Antihypertensive Drug Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
9.6 GlaxoSmithKline plc
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 Antihypertensive Drug Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Antihypertensive Drug Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
9.7 Johnson & Johnson
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 Antihypertensive Drug Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Antihypertensive Drug Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
9.8 AstraZeneca plc.
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 Antihypertensive Drug Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Antihypertensive Drug Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
9.9 Eli Lilly and Company
  9.9.1 Company Basic Information,Manufacturing Base and Competitors
  9.9.2 Antihypertensive Drug Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Antihypertensive Drug Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
9.10 Abbvie
  9.10.1 Company Basic Information,Manufacturing Base and Competitors
  9.10.2 Antihypertensive Drug Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Antihypertensive Drug Sales, Revenue, Price of Abbvie (2015 and 2016)
9.11 AMGen
  9.11.1 Company Basic Information,Manufacturing Base and Competitors
  9.11.2 Antihypertensive Drug Product Type and Technology
    9.11.2.1 Type I
    9.11.2.2 Type II
  9.11.3 Antihypertensive Drug Sales, Revenue, Price of AMGen (2015 and 2016)
9.12 Teva Pharmaceutical Industries Ltd.
  9.12.1 Company Basic Information,Manufacturing Base and Competitors
  9.12.2 Antihypertensive Drug Product Type and Technology
    9.12.2.1 Type I
    9.12.2.2 Type II
  9.12.3 Antihypertensive Drug Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
9.13 Bayer AG
  9.13.1 Company Basic Information,Manufacturing Base and Competitors
  9.13.2 Antihypertensive Drug Product Type and Technology
    9.13.2.1 Type I
    9.13.2.2 Type II
  9.13.3 Antihypertensive Drug Sales, Revenue, Price of Bayer AG (2015 and 2016)
9.14 Bristol-Myers Squibb
  9.14.1 Company Basic Information,Manufacturing Base and Competitors
  9.14.2 Antihypertensive Drug Product Type and Technology
    9.14.2.1 Type I
    9.14.2.2 Type II
  9.14.3 Antihypertensive Drug Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
9.15 Astellas Pharma
  9.15.1 Company Basic Information,Manufacturing Base and Competitors
  9.15.2 Antihypertensive Drug Product Type and Technology
    9.15.2.1 Type I
    9.15.2.2 Type II
  9.15.3 Antihypertensive Drug Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
9.16 Daiichi Sankyo
  9.16.1 Company Basic Information,Manufacturing Base and Competitors
  9.16.2 Antihypertensive Drug Product Type and Technology
    9.16.2.1 Type I
    9.16.2.2 Type II
  9.16.3 Antihypertensive Drug Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)
9.17 Abbott Laboratories
  9.17.1 Company Basic Information,Manufacturing Base and Competitors
  9.17.2 Antihypertensive Drug Product Type and Technology
    9.17.2.1 Type I
    9.17.2.2 Type II
  9.17.3 Antihypertensive Drug Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)
9.18 Yangtze River Pharmaceutical Group
  9.18.1 Company Basic Information,Manufacturing Base and Competitors
  9.18.2 Antihypertensive Drug Product Type and Technology
    9.18.2.1 Type I
    9.18.2.2 Type II
  9.18.3 Antihypertensive Drug Sales, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)
9.19 Boehringer-Ingelheim
  9.19.1 Company Basic Information,Manufacturing Base and Competitors
  9.19.2 Antihypertensive Drug Product Type and Technology
    9.19.2.1 Type I
    9.19.2.2 Type II
  9.19.3 Antihypertensive Drug Sales, Revenue, Price of Boehringer-Ingelheim (2015 and 2016)

10 ANTIHYPERTENSIVE DRUG TECHNOLOGY AND DEVELOPMENT TREND

10.1 Antihypertensive Drug Technology Analysis
10.2 Antihypertensive Drug Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES AND FIGURES

Figure Picture of Antihypertensive Drug
Table Classification of Antihypertensive Drug
Figure Europe Sales Market Share of Antihypertensive Drug by Types in 2015
Figure Central Antihypertensive Drug Picture
Figure An Antihypertensive Agent Acting on the Sympathetic Nervous System Picture
Figure Ganglion Block Drugs Picture
Figure Vasodilators Picture
Figure Adrenergic Alpha 1 Receptor Antagonist Picture
Figure Drugs that Affect the Renin-angiotensin-aldosterone System Picture
Figure Calcium Channel Blockers Picture
Table Applications of Antihypertensive Drug
Figure Europe Sales Market Share of Antihypertensive Drug by Applications in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Figure Germany Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure France Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure UK Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure Italy Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure Spain Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure Russia Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Table Europe Antihypertensive Drug Sales, Revenue and Price (2011-2021)
Figure Europe Antihypertensive Drug Sales and Growth Rate (2011-2021)
Figure Europe Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Table Europe Antihypertensive Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Antihypertensive Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antihypertensive Drug Sales Share by Manufacturers
Figure 2016 Antihypertensive Drug Sales Share by Manufacturers
Table Europe Antihypertensive Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Antihypertensive Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Antihypertensive Drug Revenue Share by Manufacturers
Table 2016 Europe Antihypertensive Drug Revenue Share by Manufacturers
Table Europe Antihypertensive Drug Sales and Market Share by Type (2011-2021)
Table Europe Antihypertensive Drug Sales Share by Type (2011-2021)
Figure Sales Market Share of Antihypertensive Drug by Type (2011-2021)
Figure Europe Antihypertensive Drug Sales Growth Rate by Type (2011-2021)
Table Europe Antihypertensive Drug Revenue and Market Share by Type (2011-2021)
Table Europe Antihypertensive Drug Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Antihypertensive Drug by Type (2011-2021)
Figure Europe Antihypertensive Drug Revenue Growth Rate by Type (2011-2021)
Table Europe Antihypertensive Drug Sales and Market Share by Regions (2011-2021)
Table Europe Antihypertensive Drug Sales Share by Regions (2011-2021)
Figure Sales Market Share of Antihypertensive Drug by Regions (2011-2021)
Figure Europe Antihypertensive Drug Sales Growth Rate by Regions (2011-2021)
Table Europe Antihypertensive Drug Revenue and Market Share by Regions (2011-2021)
Table Europe Antihypertensive Drug Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Antihypertensive Drug by Regions (2011-2021)
Figure Europe Antihypertensive Drug Revenue Growth Rate by Regions (2011-2021)
Table Europe Antihypertensive Drug Sales and Market Share by Application (2011-2021)
Table Europe Antihypertensive Drug Sales Share by Application (2011-2021)
Figure Sales Market Share of Antihypertensive Drug by Application (2011-2021)
Figure Europe Antihypertensive Drug Sales Growth Rate by Application (2011-2021)
Figure Germany Antihypertensive Drug Sales and Growth Rate (2011-2021)
Figure Germany Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure Germany Antihypertensive Drug Sales Price Trend (2011-2021)
Table Germany Antihypertensive Drug Sales by Manufacturers (2015 and 2016)
Table Germany Antihypertensive Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Antihypertensive Drug Sales by Type (2015 and 2016)
Table Germany Antihypertensive Drug Market Share by Type (2015 and 2016)
Table Germany Antihypertensive Drug Sales by Applications (2015 and 2016)
Table Germany Antihypertensive Drug Market Share by Applications (2015 and 2016)
Figure UK Antihypertensive Drug Sales and Growth Rate (2011-2021)
Figure UK Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure UK Antihypertensive Drug Sales Price Trend (2011-2021)
Table UK Antihypertensive Drug Sales by Manufacturers (2015 and 2016)
Table UK Antihypertensive Drug Market Share by Manufacturers (2015 and 2016)
Table UK Antihypertensive Drug Sales by Type (2015 and 2016)
Table UK Antihypertensive Drug Market Share by Type (2015 and 2016)
Table UK Antihypertensive Drug Sales by Applications (2015 and 2016)
Table UK Antihypertensive Drug Market Share by Applications (2015 and 2016)
Figure France Antihypertensive Drug Sales and Growth Rate (2011-2021)
Figure France Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure France Antihypertensive Drug Sales Price Trend (2011-2021)
Table France Antihypertensive Drug Sales by Manufacturers (2015 and 2016)
Table France Antihypertensive Drug Market Share by Manufacturers (2015 and 2016)
Table France Antihypertensive Drug Sales by Type (2015 and 2016)
Table France Antihypertensive Drug Market Share by Type (2015 and 2016)
Table France Antihypertensive Drug Sales by Applications (2015 and 2016)
Table France Antihypertensive Drug Market Share by Applications (2015 and 2016)
Figure Italy Antihypertensive Drug Sales and Growth Rate (2011-2021)
Figure Italy Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure Italy Antihypertensive Drug Sales Price Trend (2011-2021)
Table Italy Antihypertensive Drug Sales by Manufacturers (2015 and 2016)
Table Italy Antihypertensive Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Antihypertensive Drug Sales by Type (2015 and 2016)
Table Italy Antihypertensive Drug Market Share by Type (2015 and 2016)
Table Italy Antihypertensive Drug Sales by Applications (2015 and 2016)
Table Italy Antihypertensive Drug Market Share by Applications (2015 and 2016)
Figure Russia Antihypertensive Drug Sales and Growth Rate (2011-2021)
Figure Russia Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure Russia Antihypertensive Drug Sales Price Trend (2011-2021)
Table Russia Antihypertensive Drug Sales by Manufacturers (2015 and 2016)
Table Russia Antihypertensive Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Antihypertensive Drug Sales by Type (2015 and 2016)
Table Russia Antihypertensive Drug Market Share by Type (2015 and 2016)
Table Russia Antihypertensive Drug Sales by Applications (2015 and 2016)
Table Russia Antihypertensive Drug Market Share by Applications (2015 and 2016)
Figure Spain Antihypertensive Drug Sales and Growth Rate (2011-2021)
Figure Spain Antihypertensive Drug Revenue and Growth Rate (2011-2021)
Figure Spain Antihypertensive Drug Sales Price Trend (2011-2021)
Table Spain Antihypertensive Drug Sales by Manufacturers (2015 and 2016)
Table Spain Antihypertensive Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Antihypertensive Drug Sales by Type (2015 and 2016)
Table Spain Antihypertensive Drug Market Share by Type (2015 and 2016)
Table Spain Antihypertensive Drug Sales by Applications (2015 and 2016)
Table Spain Antihypertensive Drug Market Share by Applications (2015 and 2016)
Table Novartis Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Antihypertensive Drug Sales, Revenue, Price of Abbvie (2015 and 2016)
...


More Publications